Pharmacists 'must get involved in counterfeit medicines fight'
Staff reporter, 22-Mar-2012
Pharmacists must play an active
role in preventing patients becoming exposed to counterfeit
medicines, according to a new report from the American Pharmacists
Association (APhA).
The APhA set up a taskforce last year to look into the problem of
counterfeit medicines in the US, including practitioners in
academia, hospital, and industry, as well as an advisor from the
Food and Drug Administration (FDA).
The taskforce's recommendations have now been published in the
Journal of the American Pharmacists Association
(March/April 2012).
First and foremost, pharmacists must purchase medications from
"known, reliable sources" and beware of fraudulent distributors,
particularly in light of the current medicine shortages affecting
the US marketplace.
"A 'perfect storm' exists when legitimate suppliers of a high
demand, expensive medication are unable to supply the market needs
and counterfeiters break into the supply chain because pharmacists
are searching for alternative suppliers," says the report, which
advises pharmacists to plan for shortages with the help of the
FDA's published information on medicines in short supply.
Pharmacists should also confirm with distributors that products
were purchased from manufacturers or other reliable sources,
monitor counterfeit product alerts and examine products for
suspicious appearance, says the taskforce.
Meanwhile, pharmacists should warn patients of the dangers of
purchasing medicines over the Internet, use scanning technology in
the pharmacy as part of a prescription verification process, and
report suspicious medications to FDA, the distributor, and the
manufacturer, according to the report.
"By raising awareness, identifying education materials with
practical suggestions, and implementing recommendations to ensure
the integrity of the supply chain, pharmacists can help address the
threat of counterfeit medications," conclude the authors.
©
SecuringIndustry.com